Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Adma Biologics (ADMA) over the last 13 years, with Q3 2025 value amounting to 30.45.

  • Adma Biologics' Interest Coverage Ratio rose 16883.74% to 30.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 19.97, marking a year-over-year increase of 20011.59%. This contributed to the annual value of 9.98 for FY2024, which is 105431.06% up from last year.
  • As of Q3 2025, Adma Biologics' Interest Coverage Ratio stood at 30.45, which was up 16883.74% from 23.34 recorded in Q2 2025.
  • Over the past 5 years, Adma Biologics' Interest Coverage Ratio peaked at 30.45 during Q3 2025, and registered a low of 4.8 during Q2 2021.
  • For the 5-year period, Adma Biologics' Interest Coverage Ratio averaged around 4.67, with its median value being 0.08 (2023).
  • In the last 5 years, Adma Biologics' Interest Coverage Ratio skyrocketed by 197.06% in 2021 and then soared by 1389975.17% in 2024.
  • Over the past 5 years, Adma Biologics' Interest Coverage Ratio (Quarter) stood at 3.98 in 2021, then skyrocketed by 73.45% to 1.06 in 2022, then surged by 316.84% to 2.29 in 2023, then soared by 481.25% to 13.31 in 2024, then soared by 128.79% to 30.45 in 2025.
  • Its last three reported values are 30.45 in Q3 2025, 23.34 for Q2 2025, and 17.66 during Q1 2025.